NTG News

NDSS issues new guide on End-of-Life

Challenges in testing situations!

See how biomarkers can help diagnose Alzheimer's

NTG partners with NADSP to create ID and dementia E-Badges

National Council on Disability issues report on impact of COVID-19 and congregate care settings

FDA Approves use of Leqembi for Alzheimer's

Closure on Biogen's Aduhelm Launch - Congressional Report

ENACT Act Will Help with Inclusion in Clinical Trials

Texas-wide ID and Dementia Project ECHO Stakeholders Summit

Biogen announces positive results for Alzheimer's drug Lecanemab

Documentary Premiere: Ukraine-Paused Reforms

Spanish team finds positive effects from COVID-19 booster for adults with Down syndrome

CDC Considers Down Syndrome as a High Risk Condition for COVID-19

Disappointing Results from Amyloid Reducing Drug Trial

NTG-Canada Held In-Person Training Workshop

NTG and URI/VCU Successfully Completed its Fall 2022 ECHO Series

US Down Syndrome Coalition Responds to CMS Ruling

NTG Co-President, Dr. Seth Keller, interviewed at AAN

Joint NTG-EASPD efforts on disabilities and the current situation in the Ukraine

The NTG's Efforts to Help People with Disabilities in Ukraine